227 related articles for article (PubMed ID: 36531114)
1. Development of Squalene-Based Oil-in-Water Emulsion Adjuvants Using a Self-Emulsifying Drug Delivery System for Enhanced Antigen-Specific Antibody Titers.
Chae GE; Kim DW; Jin HE
Int J Nanomedicine; 2022; 17():6221-6231. PubMed ID: 36531114
[TBL] [Abstract][Full Text] [Related]
2. Preparation of Squalene Oil-Based Emulsion Adjuvants Employing a Self-Emulsifying Drug Delivery System and Assessment of
Bastola R; Seo JE; Keum T; Noh G; Choi JW; Shin JI; Kim JH; Lee S
Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31835466
[TBL] [Abstract][Full Text] [Related]
3. Determination of Mycoplasma hyopneumoniae-Specific IgG, IgG1, and IgG2a Titers in BALB/c Mice Induced by Mineral Oil-Based Oil-in-Water Emulsion Adjuvants Prepared Using a Self-Emulsifying Drug Delivery System.
Bastola R; Seo JE; Noh G; Keum T; Kim JH; Shin JI; Lee S; Lee S
AAPS PharmSciTech; 2019 Jan; 20(1):31. PubMed ID: 30603786
[TBL] [Abstract][Full Text] [Related]
4. A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation.
Deng J; Cai W; Jin F
Int J Pharm; 2014 Jul; 468(1-2):187-95. PubMed ID: 24704309
[TBL] [Abstract][Full Text] [Related]
5. Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4
Schmidt ST; Neustrup MA; Harloff-Helleberg S; Korsholm KS; Rades T; Andersen P; Christensen D; Foged C
Pharm Res; 2017 Aug; 34(8):1716-1727. PubMed ID: 28516400
[TBL] [Abstract][Full Text] [Related]
6. Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.
Fox CB; Barnes V L; Evers T; Chesko JD; Vedvick TS; Coler RN; Reed SG; Baldwin SL
Influenza Other Respir Viruses; 2013 Sep; 7(5):815-26. PubMed ID: 23122325
[TBL] [Abstract][Full Text] [Related]
7. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate--a revisit of the role of the hydrophile-lipophile balance (HLB) value.
Yang YW; Wei AC; Shen SS
Vaccine; 2005 Apr; 23(20):2665-75. PubMed ID: 15780450
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice.
Zhang J; Miao J; Han X; Lu Y; Deng B; Lv F; Zhao Y; Ding C; Hou J
BMC Vet Res; 2018 Dec; 14(1):415. PubMed ID: 30577861
[TBL] [Abstract][Full Text] [Related]
9. The development of self-emulsifying oil-in-water emulsion adjuvant and an evaluation of the impact of droplet size on performance.
Shah RR; Dodd S; Schaefer M; Ugozzoli M; Singh M; Otten GR; Amiji MM; O'Hagan DT; Brito LA
J Pharm Sci; 2015 Apr; 104(4):1352-61. PubMed ID: 25600347
[TBL] [Abstract][Full Text] [Related]
10. Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants.
Iyer V; Cayatte C; Guzman B; Schneider-Ohrum K; Matuszak R; Snell A; Rajani GM; McCarthy MP; Muralidhara B
Hum Vaccin Immunother; 2015; 11(7):1853-64. PubMed ID: 26090563
[TBL] [Abstract][Full Text] [Related]
11. Development of pH responsive novel emulsion adjuvant for oral immunization and in vivo evaluation.
Malik B; Gupta RK; Rath G; Goyal AK
Eur J Pharm Biopharm; 2014 Aug; 87(3):589-97. PubMed ID: 24681295
[TBL] [Abstract][Full Text] [Related]
12. An alternative renewable source of squalene for use in emulsion adjuvants.
Brito LA; Chan M; Baudner B; Gallorini S; Santos G; O'Hagan DT; Singh M
Vaccine; 2011 Aug; 29(37):6262-8. PubMed ID: 21723355
[TBL] [Abstract][Full Text] [Related]
13. Unsaturated Squalene Content in Emulsion Vaccine Adjuvants Plays a Crucial Role in ROS-Mediated Antigen Uptake and Cellular Immunity.
Huang CH; Huang CY; Huang MH
Mol Pharm; 2018 Feb; 15(2):420-429. PubMed ID: 29237267
[TBL] [Abstract][Full Text] [Related]
14. Cationic Nanoparticle-Stabilized Vaccine Delivery System for the H9N2 Vaccine to Promote Immune Response in Chickens.
Zhang Y; Zhu T; Xu S; Gu P; Cai G; Peng S; Liu Z; Yang Y; Hu Y; Liu J; Wang D
Mol Pharm; 2023 Mar; 20(3):1613-1623. PubMed ID: 36795759
[TBL] [Abstract][Full Text] [Related]
15. AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method.
Klucker MF; Dalençon F; Probeck P; Haensler J
J Pharm Sci; 2012 Dec; 101(12):4490-500. PubMed ID: 22941944
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.
Fox CB; Baldwin SL; Duthie MS; Reed SG; Vedvick TS
AAPS PharmSciTech; 2012 Jun; 13(2):498-506. PubMed ID: 22415641
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
Ott G; Barchfeld GL; Van Nest G
Vaccine; 1995 Nov; 13(16):1557-62. PubMed ID: 8578842
[TBL] [Abstract][Full Text] [Related]
18. Optimising the oil phases of aluminium hydrogel-stabilised emulsions for stable, safe and efficient vaccine adjuvant.
Yuan L; Gao XD; Xia Y
Front Chem Sci Eng; 2022; 16(6):973-984. PubMed ID: 35070473
[TBL] [Abstract][Full Text] [Related]
19. Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions.
Fox CB; Lin S; Sivananthan SJ; Dutill TS; Forseth KT; Reed SG; Vedvick TS
Pharm Dev Technol; 2011 Oct; 16(5):511-9. PubMed ID: 20550484
[TBL] [Abstract][Full Text] [Related]
20. Lycium barbarum polysaccharides-loaded Particulate Alum via Pickering emulsion as an adjuvant to enhance immune responses.
Fan Z; Zhang Y; Jiao L; Zhu T; Feng Z; Liu Z; Yang Y; Wang D
Int J Pharm; 2023 Jan; 630():122418. PubMed ID: 36423709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]